製药膜过滤市场：按产品、技术、应用和地区划分，2024-2031 年

2024-2031年製药膜过滤市场评估

随着製造商预计采用更复杂的过滤解决方案，对品质控制和产品安全的日益关注可能会推动市场成长。Verified Market Research 分析师表示，预计製药膜过滤市场的估值将在 2024 年跌至约 79.5 亿美元以下，到 2031 年将达到 182.7 亿美元。

製药膜过滤市场的快速扩张主要是由于对高纯度药品的需求不断增加，而由于更严格的监管要求，预计这一需求将会扩大。这将推动市场从2024年到2031年以12.10%的复合年增长率成长。

製药膜过滤市场定义/概述

製药膜过滤是药品生产和加工中使用的重要技术。该过程被定义为一种使用半透膜从液体中分离颗粒的分离技术，用于确保药物溶液的纯度和安全性。薄膜过滤通常用于药品製造的多个阶段，包括澄清药物溶液、去除杂质和浓缩活性成分。

由于膜技术的进步以及对更高产品品质和安全性的监管要求的不断提高，製药膜过滤预计将大幅扩展。此外，对个人化医疗和生物製剂的日益关注预计将推动对先进过滤解决方案的需求，进一步推动製药业这项基本技术的发展。

推动製药膜过滤市场发展的因素有哪些？

对药品和生物製品不断增长的需求使得高品质的药品生产受到重视。药品生产的监管标准越来越严格，需要采用先进的过滤技术来确保产品的纯度和安全性。

慢性病的流行和全球医疗基础设施的扩张预计将进一步推动对高效过滤系统的需求。膜过滤技术的进步，包括开发更有效、更耐用的材料，正在被引入以满足製药业不断变化的需求。

此外，从事药品製造的合约製造公司的成长趋势预计将支持市场扩张。使用薄膜过滤技术来改善废弃物管理和降低营运成本也受到对永续性和减少环境影响的日益关注的影响。

法规遵循和验证的潜在市场影响是什么？

法规遵循和验证对製药膜过滤市场的潜在影响是重大且多方面的。监管合规性有望确保薄膜过滤技术符合 FDA 和 EMA 等卫生当局製定的严格标准。这些标准可能会影响过滤系统的设计、製造和品质保证过程。

验证这些系统有效性和可靠性的预期验证程序可能会透过推动创新和技术发展来影响市场。随着验证过程变得更加严格，製造商预计将投资更高品质的材料和更精确的工程，以满足这些不断变化的标准。遵守这些法规预计会导致营运成本增加，但也可能提高产品的安全性和功效。

目录

第1章简介

• 市场定义
• 市场细分
• 调查方法

第 2 章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第3章市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动力
• 市场制约因素
• 市场机会
• 波特五力分析

第4章製药膜过滤市场：按膜类型

• 微滤（MF）
• 超滤（UF）
• 纳滤（NF）
• 逆渗透（RO）

第5章製药膜过滤市场：依应用分类

• 最终产品的灭菌
• 疫苗过滤
• 蛋白质纯化和浓缩
• API过滤
• 减少生物负荷

第6章製药膜过滤市场：依技术分类

• 切向流过滤（TFF）
• 正常流量过滤

第7章区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合酋长国

第8章市场动态

• 市场驱动力
• 市场制约因素
• 市场机会
• COVID-19 的市场影响

第9章 竞争格局

• 大公司
• 市场占有率分析

第10章 公司简介

• Merck KGaA（Germany）
• Danaher Corporation（US）
• Sartorius Stedim Biotech（France）
• 3M Company（US）
• Thermo Fisher Scientific Inc.（US）
• Parker-Hannifin Corporation（US）
• GE Healthcare（US）
• GEA Group（Germany）
• Pall Corporation（US）
• Koch Membrane Systems（US）

第11章市场前景与机遇

• 新兴技术
• 未来市场趋势
• 投资机会

第12章附录

• 缩写表
• 来源和参考文献

Pharmaceutical Membrane Filtration Market Valuation - 2024-2031

Enhanced focus on quality control and product safety is likely to propel market growth, as manufacturers are projected to adopt more sophisticated filtration solutions. According to the analyst from Verified Market Research, the Pharmaceutical Membrane Filtration Market is estimated to reach a valuation of USD 18.27 Billion By 2031 over the forecast subjugating around USD 7.95 Billion valued in 2024.

The rapid expansion of the pharmaceutical membrane filtration market is primarily driven by the increasing demand for high-purity pharmaceuticals, which is expected to escalate due to stricter regulatory requirements. It enables the market to grow at a CAGR of 12.10% from 2024 to 2031.

Pharmaceutical Membrane Filtration Market: Definition/ Overview

Pharmaceutical membrane filtration is a critical technology utilized in the production and processing of pharmaceutical products. Defined as a separation technique that uses a semi-permeable membrane to separate particles from liquids, this process is employed to ensure the purity and safety of pharmaceutical solutions. Membrane filtration is commonly utilized in multiple phases of pharmaceutical production, such as medication solution clarity, impurity removal, and active component concentration.

The pharmaceutical membrane filtration is anticipated to expand significantly, driven by advancements in membrane technology and increasing regulatory demands for higher product quality and safety. Additionally, the growing focus on personalized medicine and biologics is expected to fuel the demand for advanced filtration solutions, further propelling the evolution of this essential technology in the pharmaceutical industry.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What Factors are Driving the Pharmaceutical Membrane Filtration Market?

Increasing emphasis on high-quality drug production is being driven by the rising demand for pharmaceuticals and biologics. Enhanced regulatory standards for pharmaceutical manufacturing are being implemented, necessitating the adoption of advanced filtration technologies to ensure product purity and safety.

The growing prevalence of chronic diseases and the expansion of the global healthcare infrastructure are expected to further boost the demand for efficient filtration systems. Technological advancements in membrane filtration, including the development of more effective and durable materials, are being introduced to meet the evolving needs of the pharmaceutical industry.

Furthermore, it is anticipated that the growing trend of contract manufacturing companies handling pharmaceutical manufacturing will support market expansion. The use of membrane filtering technologies, which provide improved waste management and lower operating costs, is also influenced by the growing emphasis on sustainability and reducing environmental effects.

What are the Potential Impacts of Regulatory Compliance and Validation in the Market?

The potential impacts of regulatory compliance and validation on the pharmaceutical membrane filtration market are substantial and multifaceted. Regulatory compliance is anticipated to ensure that membrane filtration technologies meet stringent standards set by health authorities such as the FDA and EMA. These standards are likely to affect the design, manufacturing, and quality assurance processes of filtration systems.

Validation procedures, which are anticipated to verify the effectiveness and dependability of these systems, would probably have an impact on the market by propelling innovations and technical developments. Manufacturers are expected to invest in higher-quality materials and more precise engineering to fulfil these changing criteria as validation processes become more stringent. Compliance with these regulations is expected to increase operational costs, but it may also result in enhanced product safety and effectiveness.

Category-Wise Acumens

What are the Drivers that Contribute to the Demand for Nanofiltration?

According to VMR analysis, the demand for nanofiltration is largely propelled by the growing emphasis on the purification and concentration of pharmaceutical products. Thus, the high demand by pharmaceutical industries is enabling the nanofiltration segment to hold a major share in the market. This technology is highly valued for its ability to selectively remove contaminants while retaining valuable solutes, which is essential in ensuring the purity and efficacy of pharmaceutical formulations. The heightened focus on drug safety and quality control has led to the implementation of stricter regulatory standards, thereby necessitating advanced filtration technologies like NF to meet these requirements.

The use of nanofiltration is also being fueled by the growing complexity of pharmaceutical formulations, which includes the requirement to handle synthetic pharmaceuticals and high-value biologics. This technique is favored because it can precisely achieve high-performance separation while managing a variety of feed streams. The need for cutting-edge filtration technologies to guarantee the quality and safety of these breakthroughs is anticipated to increase as new drug discoveries and formulations are made.

What are the Potential Factors Fueling the Growth of Cell Separation in the Market?

The rapid growth of cell separation within the pharmaceutical membrane filtration market is anticipated to be driven by the rising prevalence of chronic diseases is expected to lead to an increase in demand for advanced therapeutic solutions, thereby propelling the need for effective cell separation technologies. Moreover, the expansion of biopharmaceuticals and personalized medicine is projected to boost the adoption of membrane filtration systems, as these technologies are integral to the production of high-purity biologics and the development of personalized therapies. Technological advancements in membrane materials and filtration processes are also likely to enhance the efficiency and performance of cell separation techniques, further stimulating market growth.

Additionally, increasing investments in research and development by pharmaceutical companies and research institutions are expected to foster innovation and drive the evolution of cell separation technologies. Regulatory support and the growing emphasis on stringent quality control standards in pharmaceutical manufacturing are anticipated to contribute to the market's expansion, as advanced filtration solutions are required to meet these high standards.

Country/Region-wise Acumens

How is the North American Market for Pharmaceutical Membrane Filtration Expected to Evolve in the Coming Years?

According to VMR analyst, the North American market for pharmaceutical membrane filtration is anticipated to dominate in the coming years. The market is projected to be driven by a combination of factors including increased pharmaceutical production, heightened demand for advanced filtration technologies, and stringent regulatory standards governing drug manufacturing.

Investments in research and development by major pharmaceutical companies in the region are expected to contribute to the development of innovative membrane filtration solutions, further supporting market expansion. Additionally, the rising prevalence of chronic diseases and the growing focus on improving drug safety and efficacy are likely to augment the demand for advanced filtration systems in North America.

What are the Projected Growth Prospects for the Pharmaceutical Membrane Filtration Market in Asia Pacific?

The pharmaceutical membrane filtration market in Asia Pacific is estimated to witness rapid growth due to the benefits of a burgeoning pharmaceutical industry, driven by increasing investments in healthcare infrastructure and the rising demand for high-quality pharmaceuticals.

The expansion of pharmaceutical manufacturing facilities and the growing emphasis on adhering to international quality standards are expected to fuel the need for advanced membrane filtration technologies. Additionally, the increasing adoption of biopharmaceuticals and biosimilars in the region is likely to drive demand for effective filtration solutions, positioning Asia Pacific as a rapidly growing market for pharmaceutical membrane filtration.

Competitive Landscape

The Pharmaceutical Membrane Filtration Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the pharmaceutical membrane filtration market include:

Merck KGaA

Danaher Corporation

Sartorius Stedim Biotech

3M Company

Thermo Fisher Scientific, Inc.

Parker-Hannifin Corporation

GE Healthcare

GEA Group

Pall Corporation

Koch Membrane Systems

Latest Developments

In November 2023, Repligen Corporation launched a self-contained tangential flow filtration device. It is a significant advancement in flat sheet TFF technology for ultrafiltration and diafiltration.

In October 2023, Cytiva inaugurated a new manufacturing facility in Pune, India. It specializes in bioprocessing equipment, including tangential flow filtration systems, virus filtration systems, and virus inactivation systems.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pharmaceutical Membrane Filtration Market, By Type of Membrane

• Microfiltration (MF)
• Ultrafiltration (UF)
• Nanofiltration (NF)
• Reverse Osmosis (RO)

5. Pharmaceutical Membrane Filtration Market, By Application

• Final Product Sterilization
• Vaccine Filtration
• Protein Purification and Concentration
• Active Pharmaceutical Ingredient (API) Filtration
• Bioburden Reduction

6. Pharmaceutical Membrane Filtration Market, By Technology

• Tangential Flow Filtration (TFF)
• Normal Flow Filtration

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Merck KGaA (Germany)
• Danaher Corporation (US)
• Sartorius Stedim Biotech (France)
• 3M Company (US)
• Thermo Fisher Scientific Inc. (US)
• Parker-Hannifin Corporation (US)
• GE Healthcare (US)
• GEA Group (Germany)
• Pall Corporation (US)
• Koch Membrane Systems (US)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References